1. Home
  2. DIOD vs TLX Comparison

DIOD vs TLX Comparison

Compare DIOD & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diodes Incorporated

DIOD

Diodes Incorporated

HOLD

Current Price

$91.79

Market Cap

3.9B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.94

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIOD
TLX
Founded
1959
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
DIOD
TLX
Price
$91.79
$11.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$92.67
$21.13
AVG Volume (30 Days)
675.2K
122.3K
Earning Date
05-07-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
50.53
N/A
EPS
1.33
N/A
Revenue
N/A
N/A
Revenue This Year
$18.08
N/A
Revenue Next Year
$14.46
N/A
P/E Ratio
$67.81
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$42.28
$6.28
52 Week High
$125.99
$12.48

Technical Indicators

Market Signals
Indicator
DIOD
TLX
Relative Strength Index (RSI) 47.05 55.51
Support Level $89.62 $10.12
Resistance Level $99.29 $12.35
Average True Range (ATR) 4.50 0.23
MACD -0.63 -0.06
Stochastic Oscillator 18.15 56.85

Price Performance

Historical Comparison
DIOD
TLX

About DIOD Diodes Incorporated

Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: